HALT Progression of Polycystic Kidney Disease Study A

NCT00283686 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

558

Enrollment

NIH

Sponsor class

Conditions

Kidney, Polycystic

Interventions

DRUG: Lisinopril
DRUG: Telmisartan
DRUG: Placebo
OTHER: Standard Blood Pressure Control
OTHER: Low Blood Pressure Control

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]